Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 66749

AbstractMaterial and MethodsResultsDiscussionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"

Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018

Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."

Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018

Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."

Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018

Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."

Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
On Sep 2018

Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."

Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata

Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
On Aug 2018

Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".

Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
On Aug 2018

Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".

Dr. Mamta Gupta
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018

Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.

Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."

Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
On May 11,2011

Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."

Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
On April 2011

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.

Dr. Anuradha
On Jan 2020

Important Notice

Original article / research
Year : 2012 | Month : June | Volume : 6 | Issue : 5 | Page : 794 - 800 Full Version

Detection of NDM-1 in Clinical Isolates of Klebsiella Pneumoniae from Northeast India

Published: June 1, 2012 | DOI:
Arijit Bora, Giasuddin Ahmed,

1. Assistant Professor, Department of Microbiology, College of Medical Sciences, Bharatpur, Chitwan, Nepal. 2. Professor, Department of Biotechnology, Gauhati University, Guwahati, Assam, India. Arijit Bora, Giasuddin Ahmed,

Correspondence Address :
Dr. Giasuddin Ahmed
Professor, Department of Biotechnology, Gauhati University,
Guwahati-781014, Assam, India.
Phone: +00919864104502


Introduction: The growing incidence of the resistance to carbapenems among the members of Enterobacteriaceae is of major concern throughout the world, as these drugs are often used now-a-days as the last line of effective treatment against the serious infections which are caused by multidrug resistant Enterobacteriaceae. We detected blaNDM-1 in the Klebsiella pneumoniae isolates which were collected from a tertiary care referral hospital in northeast India.
Materials and Methods: A total of 219 non-duplicated K. pneumoniae isolates were recovered from various clinical samples between August 2009 and July 2010. These isolates were screened for the detection of carbapenemase production on the basis of their reduced susceptibility to meropenem or ertapenem by the disc diffusion method. The screened isolates were further phenotypically studied for carbapenemase production by the modified Hodge test and the detection of metallo-β-lactamase production was carried out by using the combined disc test. All the screened isolates were also subjected to PCR detection of the blaNDM-1 gene and the additional bla genes which coded for TEM, SHV, CTX-M, and AmpC.
Results: Out of the 219 isolates, 19 were screened for the detection of carbapenemase production on the basis of their reduced susceptibility to meropenem or ertapenem. Both the phenotypic confirmatory tests showed positive results for all the screening positive isolates, although few weakly positive reactions for the modified Hodge test were observed. All the screened isolates were found to be positive for blaNDM-1. Each of the blaNDM-1 possessing isolates was also found to be positive for one or more additional bla genes.
Conclusion: This study indicated that the incidence of blaNDM-1, together with that of one or more additional bla genes among the K. pneumoniae isolates from hospitalized and non hospitalized patients in northeast India.


Klebsiella pneumoniae, Carbapenems, NDM-1, India

Among the newly emerged β-lactamases in the planet, New Delhi metallo-β-lactamase-1 (NDM-1) represents the latest threat in the war between the bugs and the drugs. NDM-1 is a novel type of metallo-β-lactamase that hydrolyzes all the β-lactam antibiotics except aztreonam, which is usually inactivated by the co-production of the extended-spectrum or the AmpC β-lactamases. In addition, the gene which encodes NDM-1, which is known as blaNDM-1, is located on a transmissible plasmid and its association with other resistant determinants leads to the extensive drug resistance which is exhibited by a majority of the NDM-1 producing Enterobacteriaceae, leaving only a few therapeutic options (1),(2). Therefore, the NDM-1 producing organisms are now being recognized as the world’s newest “superbugs”. In general, the term ‘‘superbugs’’ is a colloquial reference to a bacterium that carries resistance genes for many antibiotics (3).

NDM-1 was first reported in 2009 in Klebsiella pneumoniae and Escherichia coli, both of which were recovered from a Swedish patient of Indian origin, who was previously admitted to a hospital in New Delhi, India (1). Thereafter, NDM-1 has increasingly been reported from India as well as from several other parts of the world (2),(4),(5),(6). Although, blaNDM-1 (gene encoding NDM-1) has been identified in different members of Enterobacteriaceae, K. pneumoniae and E. coli still remain the most frequent NDM-1 producing isolates throughout the world. In India, NDM-1 producing K. pneumoniae have emerged as important pathogens, causing a wide range of infections, both in the community as well as in hospital settings (2), (7),(8),(9). However, the data on the prevalence of NDM-1 producing K. pneumoniae isolates in Indian hospitals is limited. We therefore designed the present study to evaluate the occurrence of blaNDM-1 in the K. pneumoniae isolates at a tertiary care referral hospital in northeast India.

Material and Methods

The Bacterial Isolates
A total of 219 non-duplicated K. pneumoniae isolates were recovered from various clinical samples such as urine (n =111), sputum (n =59), blood (n =26) and pus (n =23) at a tertiary care referral hospital in Guwahati, northeast India. The samples were obtained from both hospitalized and non-hospitalized patients between August 2009 and July 2010. The standard microbiological techniques were used for the isolation and the identification of the isolates (10). Prior to their testing, all the isolates were stored in 15% glycerol-supplemented Luria-Bertani medium at − 800C. This study was carried out with the consent of the institutional ethics committee.

Antimicrobial Susceptibility Testing
The Kirby-Bauer disc diffusion method was performed to determine the susceptibilities of the different β-lactam and non-β-lactam antibiotics and the results were interpreted as per the Clinical and Laboratory Standards Institute (CLSI) guidelines (11). All the antibiotic discs and the media were procured from Hi-media, Mumbai, India, except doripenem, which was procured from BD Diagnostics, Franklin Lakes, NJ, USA. The E.coli ATCC 25922 and the Pseudomonas aeruginosa ATCC 27853 strains were used for quality control. The minimum inhibitory concentration (MIC) values for imipenem, meropenem, ertapenem, doripenem, tigecycline and colistin were determined by using Etest strips (bioMerieux, France) as per the manufacturer’s protocol.

Screening for the Carbapenemase Production
By disc diffusion, all the isolates with a reduced susceptibility to meropenem or ertapenem (diameter of zones of inhibition, ≤ 21mm) were screened for the production of carbapenemase according to the CLSI guidelines (11).

Phenotypic Detection of the Carbapenemase Production The phenotypic detection of the carbapenemase production was performed by the modified Hodge test by using a ertapenem disc (10 μg) as was described by CLSI (11). The detection of metallo-β-lactamase production was also performed by the combined-disc test by using two imipenem discs (10 μg), one containing 10 μl of 0.1 M (292 μg) anhydrous EDTA (Sigma Chemicals, St. Louis, MO), which were placed 25 mm apart on a Mueller-Hinton agar plate (12). An increase in the zone diameter of >4 mm around the imipenem-EDTA disc as compared to that of the imipenem disc alone was considered as positive for metallo-β-lactamase production.

Molecular detection of the β-lactamase genes:

Plasmid DNA was extracted from all the screening positive isolates by using the Sure Spin Plasmid Mini Kit (Genetix Biotech Asia Ptv. Lid., India) as per the manufacturer’s protocol. The extracted plasmid DNA of each isolate was subjected to PCR detection of the blaNDM-1 gene by using the target specific primer set, NDM-Fm (5′-GGTTTGGCGATCTGGTTTTC-3′,) and NDM-Rm (5′-CGGAATGGCTCATCACGATC-3′) (13). These isolates were also examined for the presence of additional plasmid-encoded β-lactamases genes such as blaTEM, blaSHV, blaCTX-M and blaAmpC by PCR amplification as has been described elsewhere (14)(15)(16)(17). The purified PCR product of the blaNDM-1 gene for one of the randomly selected representative isolates (Kb-43) was further sequenced with the same set of primers as was used for its amplification by using a 3730XL DNA analyzer (Applied Biosystems, CA, USA), based on Sanger’s sequencing method.

The K. pneumoniae isolates which were positive for blaNDM-1 by PCR and were confirmed by gene sequencing were use as positive controls in this study.


During the study period, out of the 219 K. pneumoniae isolates, a total of 19 isolates were screened for carbapenemase production on the basis of their reduced susceptibility to meropenem or ertapenem. Out of these 19 K. pneumoniae screen positive isolates, 11(57.89%) were from urine, 03 (15.79%) were from sputum, 02 (10.53%) were from blood and 03 (15.79%) were from pus. The screening positive isolates were also found to be positive for the modified Hodge test, although 3 (15.79%) isolates gave weakly positive reactions. The combined disc test showed positive results for all the screening positive isolates. The age of the patients with the NDM-1 positive isolates ranged from 5 days to 75 years and the male to female ratio was 1.37:1

All the screening positive isolates (n =19) were found to be positive for the plasmid mediated blaNDM-1 gene by PCR (Table/Fig 1). The nucleotide sequence of the blaNDM-1 gene from the Kb-43 isolate showed 99% identity with the previously reported blaNDM-1 genes which were present in the GenBank database. The deduced nucleotide sequence of the blaNDM-1 gene from the Kb-43 isolate has been submitted to the GenBank under the accession number, JN697592. The distribution of the NDM-1 producing isolates in the different clinical samples were 9.9% (11/111), 5.08% (3/59), 7.69 (2/26) and 13.04% (3/23) for urine, sputum, blood and pus respectively (Table/Fig 2).

Furthermore, these blaNDM-1 possessing isolates were found to also be positive for one or more additional plasmid mediated bla genes (Table/Fig 3),(Table/Fig 4),(Table/Fig 5),(Table/Fig 6). The co-existence of blaNDM-1 with blaTEM, blaSHV, blaCTX-M and blaAmpC was established in 2 (10.53%) isolates, that of blaTEM, blaSHV and blaCTX was established in 3 (15.79%) isolates, that of blaTEM, blaCTX-M and blaAmpC was established in 3 (15.79%) isolates and that of blaTEM and blaCTX was established in 6 (31.58%) isolates . However, 5 (26.31%) isolates which possessed blaNDM-1 were found to be positive for only blaTEM. The frequency of the additional bla genes in the NDM-1 producing K. pneumoniae isolates are shown in (Table/Fig 7).

By disc diffusion susceptibility testing, the susceptibility of the blaNDM-1 possessing isolates (n=19) for amikacin, gentamicin, ciprofloxacin, co-trimoxazole and nalidixic acid were found to be 21.05%, 15.79%, 21.05%, 21.05% and 15.79% respectively. All the blaNDM-1 possessing isolates were found to be resistant to ampicillin, cefpodoxime, cefotaxime, ceftazidime, ceftriazone, cefepime, cefoxitin and piperacillin/ tazobactam. None the isolates were found to be susceptible to imipenem, meropenem, ertapenem or doripenem by the disc diffusion method (Table/Fig 8). The MIC values for the different carbapenems varied widely among the blaNDM-1 possessing isolates (Table/Fig 9). The range of the MIC values for imipenem, meropenem, ertapenem and doripenem were 2− >32 μg/mL, 2− >32 μg/mL, 6− >32 μg/mL and 2−>32 μg/mL respectively. The MIC value for tigecycline was ≥ 2 μg/mL (range, 0.38−2 μg/mL) and for colistin, it was > 1 μg/mL (range, 0.125−0.5 μg/mL).


The increasing reports on the NDM-1 producing Enterobacteriaceae is a major concern worldwide. Although, NDM-1 seems to be endemic in the Indian subcontinent, other reports have suggested that the Balkan countries may act as another reservoir of the NDM-1 producers [2,6,18]. Here, we are reporting the presence of NDM-1 producing K. pneumoniae isolates in various clinical samples from a tertiary care referral hospital in northeast India. The overall prevalence of the blaNDM-1 possessing K. pneumoniae isolates in our hospital was found to be 8.67% (19/219). A pervious single-day point-prevalence study which was carried out in this geographical region, reported the incidence of blaNDM-1 in a single K. pneumoniae isolate which was recovered from a surgical site infection (19). Among the 22 NDM-1 producing Enterobacteriaceae, 10 Klebsiella spp. were found to be positive for blaNDM-1 at a tertiary care centre in Mumbai (20). Recently, a very high incidence of blaNDM-1 (80%) has been reported in the K. pneumoniae strains which were collected from blood and an endotracheal aspirate from a hospital in Vellore (21). However, it is difficult to make out the exact prevalence of NDM-1 in K. pneumoniae, as this study was confined to a single hospital.

In this study, we included the samples from both hospitalized and non-hospitalized patients. Among the 19 blaNDM-1 positive K. pneumonia isolates, a majority of the isolates were recovered from the patients who were admitted to different wards and the intensive care unit (ICU). The incidence of blaNDM-1 was 84.21% (16/19) in the hospitalized patients and it was 15.79% (3/19) in the non hospitalized patients. In addition, 26.31% (5/19) blaNDM-1 positive isolates were recovered from ICU patients, of which one of the isolate was recovered from the neonatal intensive care unit (NICU). A previous study from another tertiary care centre in India also indicated the presence of NDM-1 producing K. pneumoniae in NICU patients (7).

The CLSI recommends the modified Hodge test as a phenotypic confirmatory test for the detection of carbapenemase production in Enterobacteriaceae isolates with elevated MICs for carbapenems or reduced inhibition zones in disc diffusion susceptibility testing, due to its acceptable sensitivity and specificity for carbapenemase detection. However, the sensitivity and the specificity of this test for detecting low-level metallo-β-lactamase production are not known (11). In this study, 16 (84.21%) blaNDM-1 positive K. pneumonia isolates showed clearly positive results and 3 (15.79%) isolates showed weakly positive results for the modified Hodge test. Different studies also reported the occurrence of weakly positive results for the modified Hodge test in the detection of NDM-1 producing Enterobacteriaceae (4), (22). In contrast, other studies reported false positive or false negative results which were produced by the modified Hodge test in the detection of carbapenemase producing Enterobacteriaceae [23, 24]. On the other hand, the combined disc test which was performed to detect metallo-β-lactamase production was found to be highly sensitive (100%) for the NDM-1 detection, as this test showed positive results with all the blaNDM-1 possessing K. pneumoniae isolates. The difference in the zone diameter was fairly more than 4mm for all the isolates with blaNDM-1. Therefore, our results suggest that the combined disc test can be used for the detection of NDM-1 producing K. pneumoniae isolates in any clinical laboratory on a daily basis.

The K. pneumonia isolates which possessed the blaNDM-1 gene were found to be resistant to several classes of β-lactam and non β-lactam antibiotics by disc diffusion susceptibility testing. All the isolates which possessed blaNDM-1 were resistant to imipenem, meropenem, ertapenem and doripenem by disc diffusion susceptibility testing. These isolates also exhibited a high level of resistance to the penicillins, the third and fourth generation cephalosporins, cephamycin, and aztreonam, as well as to the β-lactam–β-lactamase inhibitor combination which was tested in the study. However, few blaNDM-1 possessing isolates were found to be susceptible to amikacin, gentamicin, ciprofloxacin, co-trimoxazole and nalidixic acid. A similar type of susceptibility to the non β-lactam antibiotics in the NDM-1 producing organisms has been described in other studies from India [25, 26]. As a high-level of resistance was observed to the different classes of the β-lactam antibiotics, we also performed PCR detection for some of the important bla genes in the NDM-1 producing K. pneumonia isolates. It was observed that a majority of the isolates (73.68%) possessed two or more additional bla genes and that 26.32 % (5/19) isolates possessed only one additional bla gene in addition to blaNDM-1. The frequency of blaTEM, blaSHV, blaCTX-M and blaAmpC in the NDM-1 producing K. pneumonia isolates were 100%, 26.32%, 73.68% and 26.32% respectively. However, the sequencing of these additional bla genes could have given additional information. Previous studies from India had reported the presence of TEM-1, SHV-1, SHV-12, CTX-M-15, CMY-2 and DHA in the NDM-1 producing K. pneumonia isolates (5), (8). Other studies from abroad also showed the presence of blaTEM-1, blaSHV-11, blaSHV-28, blaCTX-M-15, and blaCMY-6 in the blaNDM-1 possessing K. pneumoniae isolates (27) (28).The incidence of blaTEM in all the blaNDM-1 possessing isolates also indicated the high prevalence of blaTEM among the β-lactam resistant K. pneumoniae in this region.

In this study, we observed that the carbapenemase production was not always associated with elevated MIC values for the different carbapenems and that the MIC values of the carbapenems varied greatly among the blaNDM-1 possessing isolates. The variations in the MIC values for the different carbapenems may be influenced by several factors, such as the type and the expression of the carbapenemase enzyme, the bacterial species and the presence of other resistance mechanisms (e.g., Extended spectrum and AmpC β-lactamases, reduced permeability and/or efflux pumps) (29). The lowest MIC values for imipenem, meropenem, ertapenem and doripenem were 2μg/mL, 2μg/mL, 6 μg/mL and 2μg/mL respectively. There was only one blaNDM-1 positive K. pneumoniae isolate in this study, for which the MIC values of all the four carbapenems were more than 32 μg/mL. In comparison to the other carbapenems, a higher MIC value for ertapenem was observed in all the blaNDM-1 positive isolates. A previous study reported that a higher resistance for ertapenem than for imipenem or meropenem may result from the combination of a β-lactamase (CTX-M or the AmpC enzyme) in addition to a decreased permeability or an increased efflux (30). In contrast, we observed a higher MIC value for ertapenem than for imipenem, meropenem and doripenem in few blaNDM-1 positive isolates with blaTEM only and these isolates were found to be negative for blaCTX-M and blaAmpC.

The MIC values for tigecycline and colistin were observed to be within the effective range for all the blaNDM-1 possessing isolates, although 21.05% (4/19) isolates showed an MIC value of 2 μg/ mL for tigecycline. The isolates may show an in vitro susceptibility to tigecycline, but the clinical experience with the carbapenem-resistant strains is limited. Although some NDM-1-producing bacteria have found to be resistant to tigecycline, this drug is usually used as one of the first line agents against the carbapenemase-producing isolates (31). During the initial studies, colistin was found to be effective in the treatment of carbapenemase producing Enterobacteriaceae, but recent reports have described the emergence of colistin resistant strains (31). These reports have threatened the world community, as there is a possibility for turning the earth back to the pre-antibiotic era.

In conclusion, carbapenem resistant K. pneumoniae have been considered as one of the greatest threats to the global health care in this century. The emergence and the spread of NDM-1 producing K. pneumoniae have heightened this threat. It has been observed that all the screening positive isolates were found to harbour the plasmid mediated blaNDM-1 gene along with one or more additional bla genes, both in hospitalized and non-hospitalized patients. The dissemination of such plasmids between different clinically important bacterial species may lead to serious public health issues, as K. pneumoniae accounts for one of the the important bacterial species in the dissemination of antibiotic resistance genes, particularly in hospital environments. Therefore, the early detection of the blaNDM-1 possessing K. pneumoniae isolates with any reduced susceptibility to the carbapenems is indispensable for the choice of the most appropriate antibiotic therapy and the implementation of efficient infection control measures.


The first author (Arijit Bora) acknowledges the University Grants Commission (UGC), India, for providing the UGC-RFSMS fellowship for carrying out his research and Department of Science and Technology (DST), Govt. of India for providing the visiting fellowship for the N.E. Research student to carry out the molecular analysis part of this study in the Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India. We are also thankful to Prof. N. K. Hazarika (Gauhati Medical College and Hospital, Guwahati, Assam, India), Prof. K. N. Prasad, Mr. S.K. Shukla (SGPGIMS, Lucknow, India), and Dr. Jayanta B. Sarma (Northumbria Healthcare NHS Foundation Trust, Tyne and Wear, UK) for their valuable advices.


Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene which was carried on a unique genetic structure in Klebsiella pneumoniae, sequence type 14 from India. Antimicrob Agents Chemother 2009; 53(12):5046-54.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10(9):597-602.
Salcido RS. Super bugs: survival of the fittest. Adv Skin Wound Care 2010; 23(10):439.
Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011; 55(3):1274-78.
Lascols C, Hackel M, Marshall SH, Hujer AM, Bouchillon S, Badal R, et al. The increasing prevalence and the dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011; 66(9):1992-97.
Struelens MJ, Monnet DL, Magiorakos AP, Santos O’Connor F, Giesecke J. The European NDM-1 Survey Participants. New Delhi metallo-beta-lactamase 1–producing Enterobacteriaceae : emergence and response in Europe. Euro Surveill 2010; 15(46):pii=19716.
Roy S, Viswanathan R, Singh AK, Das P, Basu S. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India. J Antimicrob Chemother 2011; 66(6):1411-13.
Khan AU, Nordmann P. NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae in diabetic foot ulcers in India. J Med Microbiol 2012; 61(Pt 3):454-56.
Kumarasamy K, Kalyanasundaram A. Emergence of Klebsiella pneumoniae isolates which co-produce NDM-1 with KPC-2 in India. J Antimicrob Chemother 2012; 67(1):243-44.
Collee JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology, 14th ed. Edinburgh: Churchill Livingstone.1996; 131-50
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, Twenty-First informational supplement. CLSI document M100-S21. Wayne, PA:CLSI; 2011.
Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44(9):3139-44.
Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect the NDM-1 producers. J Clin Microbiol 2011; 49(2):718-21.
Sharma J, Sharma M, Ray P. Detection of the TEM and the SHV genes in the Escherichia coli and the Klebsiella pneumoniae isolates at a tertiary care hospital in India. Indian J Med Res 2010; 132:332-6.
Lee SH, Kim JY, Lee SK, Jin W, Kang SG, Lee KJ. Discriminatory detection of extended-spectrum beta-lactamases by the restriction fragment length dimorphism-polymerase chain reaction. Lett Appl Microbiol 2000; 31(4):307-12.
Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. The prevalence and the molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47(12):3724-32.
Caccamo M, Perilli M, Celenza G, Bonfiglio G, Tempera G, Amicosante G. Occurrence of extended spectrum beta-lactamases among the isolates of Enterobacteriaceae from urinary tract infections in southern Italy. Microb Drug Resist 2006; 12(4):257-64.
Livermore DM, Walsh TR, Toleman M, Woodford N. Balkan NDM-1: escape or transplant? Lancet Infect Dis 2011; 11(3):164.
Sarma JB, Bhattacharya PK, Kalita D, Rajbangshi M. Multidrug-resistant Enterobacteriaceae which include metallo-β-lactamase producers are the predominant pathogens of healthcare-associated infections in an Indian teaching hospital. Indian J Med Microbiol 2011; 29(1):22-7.
Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: the treatment options with the carbapenems are compromised. J Assoc Physicians India 2010; 58:147-9.
Chacko B, Peter JV, Balaji V. The New Delhi Metallo-Beta-Lactamases: Their origins and implications for the intensivists. J Global Infect Dis 2011; 3:319.
Perry JD, Naqvi SH, Mirza IA, Alizai SA, Hussain A, Ghirardi S, et al. Prevalence of the faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and the evaluation of two chromogenic media. J Antimicrob Chemother 2011; 66(10):2288-94.
Carvalhaes CG, Picao RC, Nicoletti AG, Xavier DE, Gales AC. The cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 2010; 65(2):249-51.
Wang P, Chen S, Guo Y, Xiong Z, Hu F, Zhu D, Zhang Y. The occurrence of false positive results for the detection of carbapenemases in the carbapenemase-negative Escherichia coli and the Klebsiella pneumoniae Isolates. PLoS One 201; 6(10):e26356.
Seema K, Ranjan Sen M, Upadhyay S, Bhattacharjee A. Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India. J Antimicrob Chemother 2011; 66(7):1646-7.
Bharadwaj R, Joshi S, Dohe V, Gaikwad V, Kulkarni G, Shouche Y. Prevalence of New Delhi metallo-β-lactamase (NDM-1)-positive bacteria in a tertiary care centre in Pune, India. Int J Antimicrob Agents 2012; 39(3):265-66.
Samuelsen Ø, Thilesen CM, Heggelund L, Vada AN, KĂŒmmel A, Sundsfjord A. Identification of
NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother 2011 ;66(3):670-2.
Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM- 1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 2011;55(2):934-36.
Stuart CJ, Leverstein-Van Hall MA. The Dutch Working Party on the detection of highly resistant microorganisms. Guidelines for the phenotypic screening and the confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 2010; 36(3):205-10.
Woodford N, Dallow JW, Hill RL, Palepou MF, Pike R, Ward ME, et al. The ertapenem resistance among Klebsiella and Enterobacter which was submitted in the UK to a reference laboratory. Int J Antimicrob Agents 2007; 29:456–59.
Kanj SS, Kanafani ZA. Current concepts in the antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenemresistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011; 86(3):250-59.

DOI and Others

Date of Submission: Apr 08, 2012
Date of Peer Review: Apr 25, 2012
Date of Acceptance: May 25, 2012
Date of Publishing: Jun 22, 2012

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)